[Prevention of bone loss by chlorotrianisene in oophorectomized rats].
OBJECTIVE
To determine the influence of chlorotrianisene on bone metabolism in oophorectomized rats.


METHODS
Forty-eight Wistar female rats, 70 days of age, were randomly divided into four groups: SV group (sham operation + vehicle), OV group (oophorectomy + vehicle), SE group (sham (operation + chlorotrianisene) and OE group (oophorectomy + chlorotrianisene). Chlorotrianisene or vehicle 4 ml/kg was given i.p. daily for 45 days from day 7 of being ovariectomized or sham operated. At the time of death, uterine weight was measured, and the thoracic vetebra 12, left tibia were collected and made into decalcified bone specimens for histomorphometry.


RESULTS
There were significant difference in the uterine weight among each group. Significant different appearance by bone histomorphometry was seen between OV and the other three groups, but not shown between SV and SE, OE groups.


CONCLUSIONS
These results suggest chlorotrianisene could inhibit bone loss and delay the atrophy of uterus induced by ovariectomy in Wistar female rats. It has protective effects on bone like other estrogen preparations.
Zhang
J
J
First Hospital, Shuzhou Medical College.
Yang
W
W
Shen
Z
Z
D000818:Animals; D015519:Bone Density / Q000187:drug effects*; D002741:Chlorotrianisene / Q000494:pharmacology*; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology*; D005260:Female; D009929:Organ Size; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control*; D010052:Ovariectomy; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D014599:Uterus / Q000473:pathology
D004968:Estrogens, Non-Steroidal; D002741:Chlorotrianisene